Following the publication of this paper, the authors have realized that they overlooked indicating that Ting Liu and Jingjing Meng contributed equally to this work. Therefore, the affiliations for this paper should have been written as follows: Ting Liu1*, Jingjing Meng2* and Yu Zhang3. Departments of 1Nuclear Medicine and 2Thyroid and Breast Surgery, The Affiliated Wuhan Central Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014; 3Department of Surgery II, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China. *Contributed equally. Furthermore, the authors have also realized that they overlooked acknowledging a source that contributed towards the paper's funding in the Funding section of the declarations. Accordingly, the following information should have been included in the paper regarding the funding received: Funding: This work was partially supported by Shanghai Municipal Commission of Health and Family Planning (grant no. 201740175). The authors confirm that there are no further errors in the study, and all the authors agree to this correction. The authors regret their oversight, and apologize for any inconvenience caused. [the original article was published in Molecular Medicine Reports 22: 3316‑3326, 2020, DOI: 10.3892/mmr.2020.11392].
Keywords: cyclin‑dependent kinase 8; medullary thyroid carcinoma; microrna-592; proliferation.